nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—TOP1MT—nervous system—attention deficit hyperactivity disorder	0.0273	0.061	CbGeAlD
Irinotecan—TOP1MT—central nervous system—attention deficit hyperactivity disorder	0.0263	0.0588	CbGeAlD
Irinotecan—TOP1MT—cerebellum—attention deficit hyperactivity disorder	0.0257	0.0574	CbGeAlD
Irinotecan—TOP1MT—brain—attention deficit hyperactivity disorder	0.0209	0.0467	CbGeAlD
Irinotecan—CES2—cardiovascular system—attention deficit hyperactivity disorder	0.0203	0.0455	CbGeAlD
Irinotecan—TOP1—midbrain—attention deficit hyperactivity disorder	0.0175	0.0392	CbGeAlD
Irinotecan—CES1—cardiovascular system—attention deficit hyperactivity disorder	0.0167	0.0375	CbGeAlD
Irinotecan—CES2—midbrain—attention deficit hyperactivity disorder	0.0159	0.0355	CbGeAlD
Irinotecan—TOP1—cerebellum—attention deficit hyperactivity disorder	0.0135	0.0303	CbGeAlD
Irinotecan—ACHE—midbrain—attention deficit hyperactivity disorder	0.0131	0.0293	CbGeAlD
Irinotecan—CES2—nervous system—attention deficit hyperactivity disorder	0.0131	0.0292	CbGeAlD
Irinotecan—CES2—central nervous system—attention deficit hyperactivity disorder	0.0126	0.0281	CbGeAlD
Irinotecan—CES2—cerebellum—attention deficit hyperactivity disorder	0.0123	0.0275	CbGeAlD
Irinotecan—TOP1—brain—attention deficit hyperactivity disorder	0.011	0.0246	CbGeAlD
Irinotecan—CES1—nervous system—attention deficit hyperactivity disorder	0.0107	0.0241	CbGeAlD
Irinotecan—CES1—central nervous system—attention deficit hyperactivity disorder	0.0103	0.0232	CbGeAlD
Irinotecan—ACHE—cerebellum—attention deficit hyperactivity disorder	0.0101	0.0226	CbGeAlD
Irinotecan—CES2—brain—attention deficit hyperactivity disorder	0.00998	0.0223	CbGeAlD
Irinotecan—BCHE—forebrain—attention deficit hyperactivity disorder	0.00973	0.0218	CbGeAlD
Irinotecan—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00823	0.0184	CbGeAlD
Irinotecan—ACHE—brain—attention deficit hyperactivity disorder	0.00822	0.0184	CbGeAlD
Irinotecan—CES1—brain—attention deficit hyperactivity disorder	0.00822	0.0184	CbGeAlD
Irinotecan—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.00746	0.0167	CbGeAlD
Irinotecan—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00734	0.0164	CbGeAlD
Irinotecan—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.00718	0.0161	CbGeAlD
Irinotecan—BCHE—midbrain—attention deficit hyperactivity disorder	0.00643	0.0144	CbGeAlD
Irinotecan—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00621	0.0139	CbGeAlD
Irinotecan—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.0058	0.013	CbGeAlD
Irinotecan—ALB—brain—attention deficit hyperactivity disorder	0.00571	0.0128	CbGeAlD
Irinotecan—SLC22A3—brain—attention deficit hyperactivity disorder	0.0057	0.0128	CbGeAlD
Irinotecan—BCHE—nervous system—attention deficit hyperactivity disorder	0.00528	0.0118	CbGeAlD
Irinotecan—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00509	0.0114	CbGeAlD
Irinotecan—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00497	0.0111	CbGeAlD
Irinotecan—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.0048	0.0108	CbGeAlD
Irinotecan—ABCC1—brain—attention deficit hyperactivity disorder	0.00471	0.0105	CbGeAlD
Irinotecan—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00471	0.0105	CbGeAlD
Irinotecan—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00464	0.0104	CbGeAlD
Irinotecan—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00453	0.0101	CbGeAlD
Irinotecan—BCHE—brain—attention deficit hyperactivity disorder	0.00404	0.00904	CbGeAlD
Irinotecan—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00392	0.00878	CbGeAlD
Irinotecan—ABCG2—brain—attention deficit hyperactivity disorder	0.0039	0.00873	CbGeAlD
Irinotecan—CYP2B6—brain—attention deficit hyperactivity disorder	0.0036	0.00806	CbGeAlD
Irinotecan—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00356	0.00796	CbGeAlD
Irinotecan—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00342	0.00766	CbGeAlD
Irinotecan—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00306	0.00685	CbGeAlD
Irinotecan—CES1—E2F transcription factor network—EP300—attention deficit hyperactivity disorder	0.00271	0.0049	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00261	0.00473	CbGpPWpGaD
Irinotecan—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00256	0.00462	CbGpPWpGaD
Irinotecan—UGT1A1—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00254	0.00459	CbGpPWpGaD
Irinotecan—UGT1A9—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00254	0.00459	CbGpPWpGaD
Irinotecan—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00252	0.00563	CbGeAlD
Irinotecan—TOP1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00251	0.00454	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00246	0.00444	CbGpPWpGaD
Irinotecan—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00242	0.00542	CbGeAlD
Irinotecan—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00237	0.0053	CbGeAlD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00234	0.00424	CbGpPWpGaD
Irinotecan—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00234	0.00422	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00229	0.00414	CbGpPWpGaD
Irinotecan—UGT1A1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00224	0.00404	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00224	0.00404	CbGpPWpGaD
Irinotecan—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00218	0.00394	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00204	0.0037	CbGpPWpGaD
Irinotecan—UGT1A1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00199	0.0036	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00199	0.0036	CbGpPWpGaD
Irinotecan—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00198	0.00358	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00197	0.00356	CbGpPWpGaD
Irinotecan—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00194	0.00352	CbGpPWpGaD
Irinotecan—ABCB1—brain—attention deficit hyperactivity disorder	0.00192	0.00431	CbGeAlD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00189	0.00342	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00183	0.00331	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00183	0.00331	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00183	0.00331	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00179	0.00324	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00177	0.0032	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00176	0.00318	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00176	0.00317	CbGpPWpGaD
Irinotecan—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00173	0.00312	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00171	0.00309	CbGpPWpGaD
Irinotecan—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00169	0.00305	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00169	0.00305	CbGpPWpGaD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00168	0.00304	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00168	0.00304	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00163	0.00296	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00163	0.00295	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0016	0.0029	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00158	0.00286	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00157	0.00283	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00156	0.00281	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00152	0.00275	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00151	0.00273	CbGpPWpGaD
Irinotecan—UGT1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00149	0.00269	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00149	0.00269	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00148	0.00268	CbGpPWpGaD
Irinotecan—UGT1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00148	0.00267	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00148	0.00267	CbGpPWpGaD
Irinotecan—UGT1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00147	0.00265	CbGpPWpGaD
Irinotecan—UGT1A9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00147	0.00265	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00146	0.00263	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.0014	0.00254	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00139	0.00251	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00138	0.0025	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00138	0.00249	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00135	0.00244	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00125	0.00226	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00125	0.00226	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00125	0.00226	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00124	0.00224	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00124	0.00224	CbGpPWpGaD
Irinotecan—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00123	0.00223	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00123	0.00222	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00116	0.0021	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00115	0.00208	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00112	0.00202	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00106	0.00192	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00106	0.00191	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00096	0.00174	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000949	0.00172	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000942	0.0017	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000924	0.00167	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000918	0.00166	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000916	0.00166	CbGpPWpGaD
Irinotecan—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000912	0.00165	CbGpPWpGaD
Irinotecan—UGT1A9—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000911	0.00165	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000904	0.00163	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000897	0.00162	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000892	0.00161	CbGpPWpGaD
Irinotecan—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000891	0.00161	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000855	0.00155	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000841	0.00152	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000815	0.00147	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000814	0.00147	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000803	0.00145	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.0008	0.00145	CbGpPWpGaD
Irinotecan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000785	0.00142	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000785	0.00142	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000658	0.00119	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000641	0.00116	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000629	0.00114	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000623	0.00113	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000618	0.00112	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000615	0.00111	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000615	0.00111	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000608	0.0011	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000608	0.0011	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000601	0.00109	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000586	0.00106	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000585	0.00106	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000571	0.00103	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000562	0.00102	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000562	0.00102	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000557	0.00101	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000553	0.000999	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000542	0.000979	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000516	0.000932	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000514	0.000929	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000511	0.000924	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000449	0.000812	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000442	0.000799	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000442	0.000799	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000435	0.000787	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000427	0.000773	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00042	0.00076	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00042	0.000759	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00042	0.000759	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00042	0.000759	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00042	0.000759	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000417	0.000754	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000414	0.000749	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000413	0.000746	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000413	0.000746	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000412	0.000745	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000405	0.000731	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000405	0.000731	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000404	0.000731	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000398	0.00072	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000394	0.000713	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000394	0.000713	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000388	0.000702	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000386	0.000698	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000384	0.000695	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000384	0.000695	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000384	0.000694	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000384	0.000694	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000378	0.000684	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000378	0.000684	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00037	0.000669	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00037	0.000668	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000361	0.000652	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000356	0.000644	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000356	0.000644	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000353	0.000639	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000353	0.000638	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000353	0.000638	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000352	0.000636	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00035	0.000633	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000347	0.000628	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.00034	0.000615	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000338	0.000611	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000337	0.000608	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000335	0.000606	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000335	0.000606	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000334	0.000604	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000326	0.000589	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000323	0.000585	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000323	0.000583	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000319	0.000577	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000319	0.000577	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000318	0.000575	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000315	0.00057	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000308	0.000557	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000307	0.000556	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.0003	0.000543	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000293	0.000529	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000293	0.000529	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000285	0.000515	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000282	0.00051	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000279	0.000504	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000271	0.00049	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000269	0.000486	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000269	0.000486	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000268	0.000484	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000266	0.000481	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000261	0.000472	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000261	0.000472	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000258	0.000466	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000257	0.000464	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000255	0.000461	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000255	0.000461	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000254	0.00046	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000254	0.00046	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000252	0.000456	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000252	0.000456	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000251	0.000454	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000245	0.000443	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000245	0.000443	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000243	0.00044	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000239	0.000432	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000239	0.000432	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000237	0.000429	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000236	0.000427	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000233	0.000422	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000233	0.000421	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000231	0.000418	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00023	0.000416	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000224	0.000406	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00022	0.000397	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00022	0.000397	CbGpPWpGaD
Irinotecan—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000216	0.000391	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000216	0.00039	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000214	0.000387	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000214	0.000387	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000212	0.000384	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000209	0.000377	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000204	0.000369	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000201	0.000363	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000199	0.000359	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000194	0.000351	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000192	0.000348	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000192	0.000348	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000189	0.000342	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000176	0.000318	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000176	0.000318	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000172	0.000311	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.000302	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000158	0.000286	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000157	0.000284	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000155	0.000279	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000154	0.000278	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000153	0.000277	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.000265	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000146	0.000264	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000141	0.000255	CbGpPWpGaD
Irinotecan—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000133	0.000241	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000132	0.000239	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000128	0.000232	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	0.000126	0.000227	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000119	0.000214	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000214	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000117	0.000211	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000117	0.000211	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000116	0.000209	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000115	0.000208	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000109	0.000197	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	0.000109	0.000197	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000108	0.000196	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000105	0.00019	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000102	0.000185	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	9.99e-05	0.000181	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.48e-05	0.000171	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	9.25e-05	0.000167	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	9.17e-05	0.000166	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.02e-05	0.000163	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.18e-05	0.00013	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.13e-05	0.000129	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	6.78e-05	0.000123	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.63e-05	0.00012	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	5.71e-05	0.000103	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5e-05	9.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.08e-05	5.57e-05	CbGpPWpGaD
